Annual Working Capital
$210.97 M
+$23.07 M+12.28%
December 31, 2023
Summary
- As of February 12, 2025, TRDA annual working capital is $210.97 million, with the most recent change of +$23.07 million (+12.28%) on December 31, 2023.
- During the last 3 years, TRDA annual working capital has risen by +$174.38 million (+476.59%).
- TRDA annual working capital is now -27.74% below its all-time high of $291.98 million, reached on December 31, 2021.
Performance
TRDA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$394.73 M
-$8.99 M-2.23%
September 30, 2024
Summary
- As of February 12, 2025, TRDA quarterly working capital is $394.73 million, with the most recent change of -$8.99 million (-2.23%) on September 30, 2024.
- Over the past year, TRDA quarterly working capital has increased by +$177.12 million (+81.39%).
- TRDA quarterly working capital is now -2.23% below its all-time high of $403.73 million, reached on June 30, 2024.
Performance
TRDA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TRDA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.3% | +81.4% |
| 3 y3 years | +476.6% | +110.1% |
| 5 y5 years | +1259.7% | +110.1% |
TRDA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.7% | +12.3% | -2.2% | +110.1% |
| 5 y | 5-year | -27.7% | +1259.7% | -2.2% | +978.8% |
| alltime | all time | -27.7% | +1259.7% | -2.2% | +978.8% |
Entrada Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $394.73 M(-2.2%) |
| Jun 2024 | - | $403.73 M(+68.1%) |
| Mar 2024 | - | $240.23 M(+13.9%) |
| Dec 2023 | $210.97 M(+12.3%) | $210.97 M(-3.0%) |
| Sep 2023 | - | $217.61 M(-17.7%) |
| Jun 2023 | - | $264.25 M(-7.8%) |
| Mar 2023 | - | $286.54 M(+52.5%) |
| Dec 2022 | $187.90 M | $187.90 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $213.18 M(-9.6%) |
| Jun 2022 | - | $235.83 M(-8.3%) |
| Mar 2022 | - | $257.29 M(-11.9%) |
| Dec 2021 | $291.98 M(+698.0%) | $291.98 M(+150.9%) |
| Sep 2021 | - | $116.37 M(-12.6%) |
| Jun 2021 | - | $133.10 M(+263.8%) |
| Dec 2020 | $36.59 M(+135.8%) | $36.59 M |
| Dec 2019 | $15.52 M | - |
FAQ
- What is Entrada Therapeutics annual working capital?
- What is the all time high annual working capital for Entrada Therapeutics?
- What is Entrada Therapeutics annual working capital year-on-year change?
- What is Entrada Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly working capital year-on-year change?
What is Entrada Therapeutics annual working capital?
The current annual working capital of TRDA is $210.97 M
What is the all time high annual working capital for Entrada Therapeutics?
Entrada Therapeutics all-time high annual working capital is $291.98 M
What is Entrada Therapeutics annual working capital year-on-year change?
Over the past year, TRDA annual working capital has changed by +$23.07 M (+12.28%)
What is Entrada Therapeutics quarterly working capital?
The current quarterly working capital of TRDA is $394.73 M
What is the all time high quarterly working capital for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly working capital is $403.73 M
What is Entrada Therapeutics quarterly working capital year-on-year change?
Over the past year, TRDA quarterly working capital has changed by +$177.12 M (+81.39%)